New implant could help heart failure patients stay out of hospital

NCT ID NCT04012944

First seen May 24, 2026 · Last updated May 24, 2026

Summary

This study tests a small sensor implanted in the lung artery to monitor pressure in people with advanced heart failure (NYHA Class III). The goal is to see if the device is safe and accurate, helping doctors adjust treatment early to prevent hospital stays. About 81 adults will receive the implant and be followed for side effects and accuracy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE NYHA CLASS III are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cardivascular Center OLV Aalst

    Aalst, Belgium

  • Klinik für Kardiologie und Angiologie/ Studienambulanz Medizinische Hochschule Hannover (MHH)

    Hanover, Germany

  • Mater Misericordiae University Hospital

    Dublin, Ireland

  • Uniklinik Köln, Klinik III für Innere Medizin Herzzentrum der Universität zu Köln

    Cologne, Germany

  • University Hospital Galway

    Dublin, Ireland

  • Universitätsklinikum Giessen und Marburg GmbH, Standort Giessen Medizinische Klinik I, Abteilung Kardiologie und Angiologie

    Giessen, Germany

  • Ziekenhuis- Oost Limburg

    Genk, Belgium

Conditions

Explore the condition pages connected to this study.